Integrated Genetics
Executive Summary
Biotech firm's Japanese partner Toyobo Company, in conjunction with Daiichi Seiyaku Pharmaceutical, has initiated clinical trials of Integrated Genetic's tissue plasminogen activator (TPA) in the Far East. Integrated's partner in the development of a recombinant hepatitis B vaccine, Connaught, has received approval to begin Phase I clinicals of the vaccine in the U.S.